These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 4976740)
1. A trial of lipotropic enzymes in atheromatous ("arteriosclerotic") dementia. Hall P; Harcup M Angiology; 1969 May; 20(5):287-300. PubMed ID: 4976740 [No Abstract] [Full Text] [Related]
2. [Effect of calcium pangamate on the cholesterol index of atherogenicity in cerebral arteriosclerosis patients]. Rastopchin IP Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(7):1020-3. PubMed ID: 6475410 [TBL] [Abstract][Full Text] [Related]
3. [Treatment and prevention of arteriosclerotic mental disorders]. Pakesch E Wien Klin Wochenschr; 1970 Mar; 82(12):211-5. PubMed ID: 5439278 [No Abstract] [Full Text] [Related]
4. Management of chronic brain syndrome secondary to cerebral arteriosclerosis, with special reference to papaverine hydrochloride. Stern FH J Am Geriatr Soc; 1970 Jun; 18(6):507-12. PubMed ID: 4910976 [No Abstract] [Full Text] [Related]
5. [Clinical observations on the combination citrogenase-aminoxidase-tyrosine (Vasolastine)]. de Oliveira JM Hospital (Rio J); 1968 Sep; 74(3):751-4. PubMed ID: 4986696 [No Abstract] [Full Text] [Related]
6. Effect of cyclandelate on dementia. Westreich G; Alter M; Lundgren S Stroke; 1975; 6(5):535-8. PubMed ID: 1101457 [TBL] [Abstract][Full Text] [Related]
7. [Biochemical and EEG studies of disorders with neurastheniform onset in chronic cerebral circulatory insufficiency of atheromatous origin]. Popoviciu L; Grecu F Stud Cercet Neurol; 1967; 12(6):429-44. PubMed ID: 6082538 [No Abstract] [Full Text] [Related]
8. [On a strange case of wandering in an arteriosclerotic demented patient]. Soverini S; Borghesi E G Gerontol; 1968 Aug; 16(8):846-51. PubMed ID: 5740963 [No Abstract] [Full Text] [Related]
9. [Clinical experience with treatment by piracetam in gerontopsychiatry (author's transl)]. Vencovský E; Hronek J; Drahokoupil L; Fait V; Hudcová T; Laciga Z; Vanková H Cesk Psychiatr; 1980 Apr; 76(2):89-97. PubMed ID: 6994907 [No Abstract] [Full Text] [Related]
10. Treatment of the cerebral manifestations of arteriosclerosis with cyclandelate. Young J; Hall P; Blakemore C Br J Psychiatry; 1974 Feb; 124(579):177-80. PubMed ID: 4596673 [No Abstract] [Full Text] [Related]
11. [Senile, presenile and arteriosclerotic dementia. Psychological and laboratory aspects studied in the light of treatment with neurohomologous phospholipids]. Colafelice M; Castellani A; Perbellini D Acta Neurol (Napoli); 1977; 32(3):332-9. PubMed ID: 883527 [No Abstract] [Full Text] [Related]
12. [Examination of cerebral vessels in senile and arteriosclerotic dementia]. Hackl H Med Monatsschr; 1965 Nov; 19(11):514-6. PubMed ID: 5885623 [No Abstract] [Full Text] [Related]
17. [Use of vasolastin in patients with coronary arteriosclerosis]. Bobkova VI; Dergacheva IuG; Martynov AI Kardiologiia; 1969 Dec; 9(12):76-81. PubMed ID: 5383791 [No Abstract] [Full Text] [Related]
18. 2,5-dimethoxy-4-methylamphetamine: clinical evaluation of a new hallucinogenic drug. Faillace LA; Synder SH; Weingartner H J Nerv Ment Dis; 1970 Feb; 150(2):119-26. PubMed ID: 4392056 [No Abstract] [Full Text] [Related]
19. [Clinical studies on the geriatric agent Kavaform. Double blind tests]. Hun N; Villányi P; Mérei F; Venter V Munch Med Wochenschr; 1967 Oct; 109(42):2197-202. PubMed ID: 4887620 [No Abstract] [Full Text] [Related]
20. Enzyme therapy in experimentally produced atherosclerosis. Mawdesley-Thomas LE Enzymologia; 1966 Aug; 31(2):65-82. PubMed ID: 4988029 [No Abstract] [Full Text] [Related] [Next] [New Search]